Skip to main content

Table 2 The 10-year cardiovascular risk in individuals with and without metabolic syndrome according to baseline characteristics

From: Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study

Variables

CVD risk categories

With MetS

Without MetS

Low risk

Moderate risk

High risk

P-value*

Low risk

Moderate risk

High risk

P-value*

Age; years (mean ± SD)

46.6 ± 7.8

54.8 ± 7.9

59.5 ± 6.9

< 0.001

44.2 ± 7.6

53.5 ± 7.4

60.2 ± 6.6

< 0.001

Sex, female/male

1097/125

282/129

106/189

< 0.001

3168/2159

139/987

20/543

< 0.001

WC, cm

101.6 ± 9.4

101.2 ± 10.5

102.5 ± 9.9

0.20

90.5 ± 11.3

89.1 ± 10.4

90.6 ± 9.6

0.0003

SBP, mmHg

113.7 ± 15.8

129.4 ± 16.9

138.4 ± 20.9

< 0.001

104.3 ± 13.6

114.0 ± 17.5

126.0 ± 19.9

< 0.001

DBP, mmHg

77.5 ± 11.9

83.7 ± 11.3

87.4 ± 11.7

< 0.001

71.2 ± 10.3

75.3 ± 11.6

80.7 ± 12.1

< 0.001

TC, mg/dl

193.6 ± 38.5

204.3 ± 43.2

205.2 ± 46.6

< 0.001

179.9 ± 36.4

189.2 ± 37.7

190.1 ± 35.2

< 0.001

HDL, mg/dl

44.4 ± 12.5

45.3 ± 12.7

43.5 ± 15.8

0.07

53.8 ± 16.6

49.1 ± 14.7

47.7 ± 13.8

< 0.001

LDL, mg/dl

111.1 ± 33.2

118.0 ± 36.4

118.6 ± 39.2

0.0001

104.2 ± 30.7

114.3 ± 31.8

116.6 ± 29.6

< 0.001

TG, mg/dl

184.7 ± 93.3

204.9 ± 126.9

215.2 ± 135.5

< 0.001

109.1 ± 57.0

128.2 ± 75.7

128.5 ± 81.8

< 0.001

FBS, mg/dl

100.4 ± 37.1

115.0 ± 50.8

122.4 ± 54.9

< 0.001

85.8 ± 15.4

89.7 ± 25.1

92.6 ± 25.6

< 0.001

  1. *One way ANOVA